Full name
IMMULAB SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
IMMULAB SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. JÓZEFA MARCIKA 6, 30-443 KRAKÓW
TAX ID6762577178
Rate company:
IMMULAB SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID6762577178
KRS0000826365
Share capital5,000.00 zł
address
UL. JÓZEFA MARCIKA 6, 30-443 KRAKÓW
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
6762577178
REGON
385425994
KRS
0000826365
Legal form
limited liability company
Register Address
UL. JÓZEFA MARCIKA 6, 30-443 KRAKÓW
Date of registration in KRS
2020-01-30
Date of commencement of economic activity
2020-01-30
Act signature
RDF/664503/24/782
Pkd codes
72.11.Z - Research and experimental development on biotechnology
20.42.Z - Manufacture of perfumes and toilet preparations
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.46.Z - Wholesale of pharmaceutical goods
46.76.Z - Wholesale of other intermediate products
47.99.Z - Other retail sale not in stores, stalls or markets
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
Payer VAT status
Active
Vat list bank account(s)
PL49 1240 1444 1111 0010 9653 3959 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2022 | 2023 | ||
|---|---|---|---|
K PLN | K PLN | % | |
Profit (loss) on sale  | 1,4 | -3,3 | -336,1 |
Gross profit (loss) | 1,4 | -3,3 | -337,5 |
EBITDA | 1,4 | -3,3 | -336,1 |
Short time liabilities | 1,6 | 0,1 | -94,7 |
Other operating costs | 0 | 0 | 0 |
Equity capital | 3,2 | -0,2 | -105,2 |
Operating profit (EBIT) | 1,4 | -3,3 | -336,1 |
Assets | 20,7 | 15,9 | -23,2 |
Net profit (loss) | 1,4 | -3,3 | -337,5 |
Cash | 18,5 | 12,8 | -30,9 |
Net income from sale | 8,7 | 6,3 | -27,1 |
Liabilities and provisions for liabilities | 17,6 | 16,1 | -8,5 |
Working assets | 20,7 | 15,9 | -23,2 |
Other income costs | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | 44,3 | 2036,1 | 1991,8 |
Equity capital to total assets | 15,2 | -1 | -16,2 |
Gross profit margin | 16,1 | -52,4 | -68,5 |
EBITDA Margin | 16,2 | -52,4 | -68,6 |
Days | Days | Days | |
Short term commitment turnover cycle | 66 | 5 | -61 |
Current financial liquidity indicator | 13.132323265075684 | 191.16270446777344 | 178,1 |
Net dept to EBITDA | -1.7471981048583984 | -0.9780960083007812 | 0,7 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
INVIGEN SPÓŁKA AKCYJNA
WARSZAWA
Molecular Biotech Mateusz Gielata
Warszawa
Bartosz Wasąg
Gdańsk
Magdalena Antonijczuk-Krzyśków
TYNIEC MAŁY
JAROSZ BOŻENA
Lublin
KAROLINA BADORA
Romanówka